These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36430344)

  • 1. Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications.
    Su PW; Chen BS
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
    Lin YC; Chen BS
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Target Identification and Drug Repurposing in Psoriasis through Systems Biology Approach, DNN-Based DTI Model and Genome-Wide Microarray Data.
    Zhan YP; Chen BS
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
    Ting CT; Chen BS
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method.
    Yeh SJ; Yeh TY; Chen BS
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications.
    Chang S; Chen JY; Chuang YJ; Chen BS
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems Biology Methods via Genome-Wide RNA Sequences to Investigate Pathogenic Mechanisms for Identifying Biomarkers and Constructing a DNN-Based Drug-Target Interaction Model to Predict Potential Molecular Drugs for Treating Atopic Dermatitis.
    Chou SP; Chuang YJ; Chen BS
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and Epigenetic Host-Virus Network to Investigate Pathogenesis and Identify Biomarkers for Drug Repurposing of Human Respiratory Syncytial Virus via Real-World Two-Side RNA-Seq Data: Systems Biology and Deep-Learning Approach.
    Hsu BW; Chen BS
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal Cancer.
    Yeh SJ; Chen SW; Chen BS
    Front Genet; 2020; 11():117. PubMed ID: 32211020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms.
    Yeh SJ; Hsu BJ; Chen BS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
    Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems Medicine Design based on Systems Biology Approaches and Deep Neural Network for Gastric Cancer.
    Yeh SJ; Chen BS
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(5):3019-3031. PubMed ID: 34232888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating Core Signaling Pathways of Hepatitis B Virus Pathogenesis for Biomarkers Identification and Drug Discovery via Systems Biology and Deep Learning Method.
    Chang S; Wang LH; Chen BS
    Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32878239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.
    Woerl AC; Eckstein M; Geiger J; Wagner DC; Daher T; Stenzel P; Fernandez A; Hartmann A; Wand M; Roth W; Foersch S
    Eur Urol; 2020 Aug; 78(2):256-264. PubMed ID: 32354610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-Molecule Drug Design Based on Systems Biology Approaches and Deep Neural Network to Mitigate Human Skin Aging.
    Yeh SJ; Lin JF; Chen BS
    Molecules; 2021 May; 26(11):. PubMed ID: 34073305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis.
    Isali I; McClellan P; Calaway A; Prunty M; Abbosh P; Mishra K; Ponsky L; Markt S; Psutka SP; Bukavina L
    Urol Oncol; 2022 May; 40(5):197.e11-197.e23. PubMed ID: 35039218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
    Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G
    Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the Role of Obesity in Prostate Cancer and Identifying Biomarkers for Drug Discovery: Systems Biology and Deep Learning Approaches.
    Yeh SJ; Chung YC; Chen BS
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer.
    Lyu L; Xiang W; Zhu JY; Huang T; Yuan JD; Zhang CH
    Cancer Manag Res; 2019; 11():6061-6077. PubMed ID: 31308745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network Biomarkers of Bladder Cancer Based on a Genome-Wide Genetic and Epigenetic Network Derived from Next-Generation Sequencing Data.
    Li CW; Chen BS
    Dis Markers; 2016; 2016():4149608. PubMed ID: 27034531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.